- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03106090
Studying Survivorship Care Plans in Head and Neck Cancer
14 de enero de 2020 actualizado por: Duke University
Comparison of Enhanced Survivorship Care Plans in a Head and Neck Cancer Clinic to Standard of Care
The study will focus on survivorship care for head and neck cancer patients cared for within Duke Cancer Center clinics.
Standardized survivorship care plans (sSCP) are being implemented based on the American Society for Clinical Oncology's criteria.
These documents provide a summary of treatment received, and list side effects and follow-up information after cancer treatment.
Taking advantage of this transition, the investigator will study three groups of patients: (a) early survivors treated before the sSCP was implemented, (b) early survivors treated after the sSCP was implemented, and (c) current patients who will receive an individualized enhanced SCP (eSCP), which will include additional information tailored to patient preferences.
The investigators hypothesize that patients receiving enhanced survivorship care plans will increase their knowledge regarding their health care plan and wellness trajectory; increase their ability to identify the symptoms they most likely can expect as a result of their cancer treatment; and be more likely to engage in conversations with their PCP about healthy behaviors and screening guidelines.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Actual)
6
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
North Carolina
-
Durham, North Carolina, Estados Unidos, 27710
- Duke Health, Duke Cancer Center
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Completed treatment for a head or neck cancer at Duke Cancer Center within 4 months of consent OR
- Will complete treatment for a head and neck cancer at Duke Cancer Center within 3 weeks of consent AND
- Able to read and understand English
- Capable of giving informed consent
- Are at least age 18.
Exclusion Criteria:
- incompetent for interview (documented diagnosis of active psychosis or dementia) or unable to provide informed consent as assessed by the interviewer; or too sick to participate, as judged by a member of the research team
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Sin intervención: No SCP Control
Patients returning for early follow-up who did not receive SCP.
|
|
Sin intervención: SOC SCP Control
Patients returning for early follow-up who received a standard of care SCP.
|
|
Experimental: eSCP Intervention
Patients currently receiving treatment who will be enrolled to receive an "enhanced" SCP (eSCP) with additional information beyond ASCO guidelines tailored to patient concerns and preferences.
|
The eSCP includes a treatment summary section, a section detailing follow-up and test recommendations, a section on anticipated and potential side effects, as well as additional information specific to their experience/concerns.
They will receive a patient education notebook outlining symptoms and their management that is tailored to those that the subject may be likely to experience during their survivorship care trajectory.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Head and Neck Cancer Survivor Knowledge
Periodo de tiempo: 5 minutes to complete 3 months after treatment end
|
Assesses survivor knowledge of potential cancer or treatment-related symptoms and knowledge of healthy behaviors through the use of the Head and Neck Cancer Survivor Knowledge Scale
|
5 minutes to complete 3 months after treatment end
|
Change in Head and Neck Cancer Survivor Knowledge
Periodo de tiempo: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses survivor knowledge of potential cancer or treatment-related symptoms and knowledge of healthy behaviors through the use of the Head and Neck Cancer Survivor Knowledge Scale in intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Distress in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete 3 months after treatment end
|
Assesses risk of distress defined within post-traumatic stress after treatment through the use of the PTSD Checklist
|
5 minutes to complete 3 months after treatment end
|
Distress in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete 3 months after treatment end
|
Assesses distress through the use of the NCCN Distress Thermometer
|
5 minutes to complete 3 months after treatment end
|
Change in distress for head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses risk of distress defined within post-traumatic stress after treatment through the use of the PTSD Checklist in the intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Change in distress for head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses distress through the use of the NCCN Distress Thermometer in the intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Uncertainty in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete 3 months after treatment end
|
Assesses uncertainty related to presence of symptoms after cancer treatment through the use of the Mishel Uncertainty in Illness Scale -Survivor/Caregiver form
|
5 minutes to complete 3 months after treatment end
|
Change in uncertainty in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses uncertainty related to presence of symptoms after cancer treatment through the use of the Mishel Uncertainty in Illness Scale -Survivor/Caregiver form in the intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Quality of life in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete 3 months after treatment end
|
Assesses quality of life in head and neck cancer patients EORTC Quality of Life Questionnaire Head & Neck (QLQ H&N35)
|
5 minutes to complete 3 months after treatment end
|
Change in quality of life in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses quality of life in head and neck cancer patients EORTC Quality of Life Questionnaire Head & Neck (QLQ H&N35) in the intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Self-efficacy in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete 3 months after treatment end
|
Assesses self-efficacy in cancer patients through the use of the Self-Efficacy Scale
|
5 minutes to complete 3 months after treatment end
|
Change in self-efficacy in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses self-efficacy in cancer patients through the use of the Self-Efficacy Scale
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Information processing in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete 3 months after treatment end
|
Assesses information processing in cancer patients through the use of the EORTC QLQ Information Module (QLQ INFO25)
|
5 minutes to complete 3 months after treatment end
|
Change in information processing in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses information processing through the use of the EORTC QLQ Information Module (QLQ INFO25)
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Survivorship care plan perceptions in head and neck cancer survivors
Periodo de tiempo: 5 minutes to complete 3 months after treatment end
|
Using open ended questions during a qualitative interview, survivors will provide their perception of how survivorship care plans were useful or not in their care
|
5 minutes to complete 3 months after treatment end
|
Survivorship needs after treatment completion -- primary care provider documentation
Periodo de tiempo: 10 minutes to complete documentation review of 6 months of PCP records
|
Using a documentation checklist developed by the study team, discussions on survivorship needs when returning to clinic will be assessed with a focus on symptom management or incorporation of healthy behaviors to reduce cancer recurrence
|
10 minutes to complete documentation review of 6 months of PCP records
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Deborah H Allen, PhD, RN, Duke Health
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
19 de abril de 2017
Finalización primaria (Actual)
2 de enero de 2020
Finalización del estudio (Actual)
2 de enero de 2020
Fechas de registro del estudio
Enviado por primera vez
29 de marzo de 2017
Primero enviado que cumplió con los criterios de control de calidad
4 de abril de 2017
Publicado por primera vez (Actual)
10 de abril de 2017
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
18 de enero de 2020
Última actualización enviada que cumplió con los criterios de control de calidad
14 de enero de 2020
Última verificación
1 de enero de 2020
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- Pro00079937
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre educational materials
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)Terminado